PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, PDL's president and chief executive officer, will present at two investor conferences in March. Cowen and Company 37th

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around the world,...

root9B Holdings, Inc. (NASDAQ: RTNB) ("Company") today announced that it will attend the 29th Annual ROTH Conference in Dana Point, CA. The Company's management will conduct one-on-one meetings...

Xilinx, Inc. (NASDAQ: XLNX) is demonstrating responsive and reconfigurable vision guided intelligent systems at Embedded World 2017. Conference presentations and demonstrations will show how...

MaxCyte, a US-based global company dedicated to accelerating the discovery, development, manufacturing and commercialization of next-generation, cell-based medicines, announced today it will...